Search Results 1221-1230 of 21247 for Informed consent

1. A Study Of The Safety And Effectiveness Of Chronic Subcutaneous CD-NP For Renal Blood Vessel Protection For Patients Who Have Heart Failure And An LVAD - Mayo Clinic

   Willing to provide informed consent; All cardiac medications must be at stable doses 4 weeks prior to enrollment. Exclusion Criteria. Known allergy or other ...

2. NLA101 in Adults Receiving High Dose Chemotherapy for AML - Mayo Clinic

   Participation eligibility · Signed written informed consent obtained prior to any study procedures. · Age ≥ 18 (or legal age of majority for sites outside US).

3. A Study of the Underlying Physical Characteristics of a Graft Leading to Survival in Liver Transplant - Mayo Clinic

   Participation eligibility · Age 18 and older · Has liver disease that warrants liver transplant evaluation · Provision of informed consent by patient, responsible ...

4. A Study Assessing Compliance with Mercaptopurine Treatment in Children with Acute Lymphoblastic Leukemia in First Remission - Mayo Clinic

   All patients and/or their parents or legal guardians must sign a written informed consent. All institutional, Food and Drug Administration (FDA), and ...

5. Natural History Study Protocol in PMM2-CDG (CDG-Ia) - Mayo Clinic

   Informed consent/assent by the patient and/or their legally authorized representative; Confirmed diagnosis of PMM2-CDG, based on enzymatic or molecular tests ...

6. Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients

   * Patients taking subcutaneous (SQ) insulin either via multidose injections or SQ insulin pump. * Capable of giving signed informed consent. Exclusion ...

7. A Study to Evaluate CC-96191 to Treat Participants With Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

   Participant must understand and voluntarily sign an informed consent form (ICF) prior to any study-related assessments/procedures being conducted. 3 ...

8. Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

   ... informed consent document -Willing to provide tissue samples for correlative research purposes Exclusion Criteria: -Unresolved toxicity of National Cancer ...

9. Efficacy And Safety Of SANGUINATE™ For Reduction Of Delayed Graft Function In Patients Receiving A Kidney Transplant - Mayo Clinic

   Able to understand and provide written informed consent. Male or female subject at least 18 years of age. Dialysis-dependent renal failure initiated at ...

10. CNS Autoantibody and Inflammatory Marker Investigation in Catatonia - Mayo Clinic

    Inability or lack of willingness to obtain informed consent from patient or legal authorized representative. Involuntary treatment or hospitalization; Out ...